Key Points
- The Indian Council of Medical Research (ICMR) has developed a new tuberculosis (TB) diagnostic device using CRISPR technology.
- This device can test over 1,500 samples in just 2.5 hours, compared to traditional methods which can take up to 42 days.
- The cost of using the new device is only ₹35 per test.
- ICMR is looking for partners to help commercialize this device and make it widely available.
Looma News
The Indian Council of Medical Research (ICMR) has unveiled an exciting new tool for diagnosing tuberculosis (TB), a disease that affects millions globally. This breakthrough device, developed at ICMR’s regional center in Dibrugarh, Assam, utilizes CRISPR technology to provide rapid and affordable TB testing. The device is capable of processing over 1,500 samples in just 2.5 hours, a significant improvement over traditional testing methods which can take up to 42 days to deliver results.
The CRISPR-based system stands out not only for its speed but also for its cost-effectiveness. Each test costs just ₹35, making it highly accessible, especially in resource-limited settings. This is a major step forward from older methods that are more time-consuming and expensive, often requiring complex equipment and procedures.
Significance of the New Device
The rapid testing capabilities of this device could dramatically improve TB diagnosis and treatment. Early detection is crucial for controlling TB outbreaks and ensuring that patients receive timely care. The new device’s efficiency means that healthcare providers can process large numbers of samples quickly, leading to faster diagnosis and better outcomes for patients.
Strategic Context and Future Plans
ICMR is now seeking partners to help bring this innovative technology to market. By inviting organizations and manufacturers to participate in the commercialization process, ICMR aims to ensure that the device becomes widely available and can have a global impact. The collaboration will include technical support and guidance from ICMR-RMRCNE, aiming to streamline production and distribution.
In summary, this new TB detection system represents a significant leap forward in medical diagnostics, combining speed, affordability, and portability to tackle a pressing health challenge.
